http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013150349-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-12 |
| filingDate | 2012-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013150349-A |
| titleOfInvention | 5-SUBSTITUTED IMINOTIAZINES AND THEIR MONO- AND DIOXIDES AS YOUR INHIBITORS CONTAINING THEIR COMPOSITIONS AND THEIR APPLICATION |
| abstract | 1. A compound or stereoisomer of said compound or a pharmaceutically acceptable salt of said compound or said stereoisomer, wherein said compound has structural formula (I): or a tautomer thereof having structural formula (I '): or a pharmaceutically acceptable salt thereof, wherein W is selected from the group consisting of S, S (O) and S (O); R and R are each independently selected from the group consisting of H, halogen, alkyl, alkoxy, haloalkyl, heteroalkyl, alkenyl, alkynyl, aryl, -alkyl-aryl, monocyclic heteroaryl, -alkyl- (monocyclic teroaryl), monocyclic cycloalkyl, -alkyl- (monocyclic cycloalkyl), monocyclic heterocycloalkyl, -alkyl- (monocyclic heterocycloalkyl), polycyclic group and -alkyl- (polycyclic group); wherein said alkyl, alkoxy, haloalkyl, heteroalkyl, aryl, -alkyl-aryl, monocyclic heteroaryl, -alkyl- (monocyclic heteroaryl), monocyclic cycloalkyl, -alkyl- (monocyclic cycloalkyl), monocyclic heterocycloalkyl, -alkyl- (monocyclic heterocycloalkyl), polycyclic groups , -alkyl- (polycyclic group) R and R each are optionally and independently unsubstituted or substituted by one or more groups independently selected from R; ring A is selected from the group consisting of aryl, monocyclic heteroaryl, monocyclic cycloalkyl, monocyclic cycloalkenyl, monocyclic heterocycloalkyl, monocyclic heterocycloalkenyl and a polycyclic group; ring B (if present) is independently selected from the group consisting of aryl, monocyclic heteroaryl, monocyclic cycloalkyl |
| priorityDate | 2011-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.